Azetukalner for major depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 4 registered trials.

Why this status

  1. 18 Mar 2025: Trial started, NCT06922110
  2. 10 Apr 2025: Trial registered, NCT06922110
  3. 8 Jul 2025: Trial started, NCT07076407
  4. 22 Jul 2025: Trial registered, NCT07076407

The trials

NCT05376150: A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder

State
Completed
Phase
Phase 2
People
168 taking part
Started
19 May 2022
Primary completion
18 Sep 2023
Arms
XEN1101 10 mg, XEN1101 20 mg
Results
Posted on the registry
Papers
doi:10.1001/jamanetworkopen.2025.14278
  1. 17 May 2022: Trial registered
  2. 19 May 2022: Trial started
  3. 16 Oct 2023: Trial completed
  4. 21 Sep 2026: Trial results posted

NCT06775379: A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

State
Stopped early
Phase
Phase 3
People
357 taking part
Started
20 Dec 2024
Primary completion
28 Oct 2026
Arms
Azetukalner
Results
None posted
  1. 20 Dec 2024: Trial started
  2. 15 Jan 2025: Trial registered
  3. 28 Oct 2026: Trial terminated

NCT06922110: An Open-Label Study of Azetukalner in Major Depressive Disorder

State
Under way
Phase
Phase 3
People
460 planned
Started
18 Mar 2025
Primary completion
Jan 2027
Arms
Azetukalner 20 mg
Results
None posted
  1. 18 Mar 2025: Trial started
  2. 10 Apr 2025: Trial registered

NCT07076407: A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

State
Under way
Phase
Phase 3
People
450 planned
Started
8 Jul 2025
Primary completion
May 2027
Arms
Azetukalner
Results
None posted
  1. 8 Jul 2025: Trial started
  2. 22 Jul 2025: Trial registered

How the status changed

  1. 16 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as XEN1101 10 mg, XEN1101 20 mg.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.